Drawing for GEODE

USPTO serial 90664301

GEODE

Reviewed by CopyMark Law Group

Reg. 8161443Status 700Registered
Filing date
Status date
Registration date
Mar 3, 2026
Examiner
REINHART, MEGHAN M
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GEODE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wade Savoy

Wade Savoy Outside General Counsel, LLP501 Boylston Street, 10th FloorBoston, MA 02116United States

Goods and services

ClassDescriptionStatusFirst use
042Biotechnology and pharmaceutical testing, research, development, and analysis; pharmaceutical, biomedical, and biological therapeutic research and services; pharmaceutical research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields; research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors (GPCRs); research services in biology fields; pharmaceutical research services in biological drug discovery and development; pharmaceutical research and development services for identifying lead biologics; research and development services in the creation of libraries or collections of biologicals; pharmaceutical research and development in the nature of research, creation, and development of biological drug targets for non-medical scientific screening purposes; pharmaceutical research, analysis, and examination for identification of biologics through automated screening processes; laboratory research, screening, evaluation, and development of biologics; research, studies, and development in the field of pharmaceuticals and biologics; research and development services in biological pharmaceutical development; medical and pharmacological research services; analysis and measurement of pharmaceutical, biomedical, and biological molecules and characteristics; bioanalysis services; biochemical analysis; research and development of medicines; research and development services in the field of antibodies and small proteins; research and development services in the field of antibody and small protein technology; research relating to molecular sciences; research relating to pharmaceuticals; scientific and pharmaceutical research and development, namely, use of in silico, in vitro, and in vivo methods and procedures for biologic, drug, and target production, manipulation, screening, selection, and assaying; provision of information, advisory services, and consultancy relating to the aforesaid servicesACTIVEMar 20, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jul 8, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jun 29, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jun 17, 2026PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Jun 15, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 6, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Mar 3, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 3, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 11, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 11, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 10, 2026ALIEASSIGNED TO LIE—
Feb 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2025DOCKASSIGNED TO EXAMINER—
Jan 27, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 27, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 26, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 22, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 25, 2024IUAFUSE AMENDMENT FILED—
Apr 25, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 10, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 8, 2023EX3GSOU EXTENSION 3 GRANTED—
Nov 8, 2023EXT3SOU EXTENSION 3 FILED—
Nov 8, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 20, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 18, 2023EX2GSOU EXTENSION 2 GRANTED—
Apr 18, 2023EXT2SOU EXTENSION 2 FILED—
Apr 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 9, 2022EX1GSOU EXTENSION 1 GRANTED—
Nov 9, 2022EXT1SOU EXTENSION 1 FILED—
Nov 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 1, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 1, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 1, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 1, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 1, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 10, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2021DOCKASSIGNED TO EXAMINER—
Nov 2, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 2, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 2, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance